By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Qianhai Health Holdings Limited (0911.HK)

HKSE Currency in HKD
$0.30
-$0.01
-1.67%
Last Update: 29 Aug 2025, 08:08
$50.83M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.14 - $0.72
52 Week Range

0911.HK Stock Price Chart

Explore Qianhai Health Holdings Limited interactive price chart. Choose custom timeframes to analyze 0911.HK price movements and trends.

0911.HK Company Profile

Discover essential business fundamentals and corporate details for Qianhai Health Holdings Limited (0911.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

27 Jun 2014

Employees

14.00

CEO

Chee Lap Yuen

Description

Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, and skincare and other health-care products to wholesalers and retailers, as well as American ginseng, a perennial plant. The company is also involved in the sale of electronic components, including central processing unit, semi-conductor, etc. In addition, it engages in the trading of health-care products and electronic components; and money lending business. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.

0911.HK Financial Timeline

Browse a chronological timeline of Qianhai Health Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 24 Mar 2025

EPS came in at -$0.08 , while revenue for the quarter reached $212.73M .

Earnings released on 22 Aug 2024

EPS came in at $0.09 , while revenue for the quarter reached $306.97M .

Stock split effective on 13 Jun 2024

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 7 Jun 2024

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 4 Jun 2024

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 20 May 2024

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 Mar 2024

EPS came in at $0.35 , while revenue for the quarter reached $621.39M .

Earnings released on 22 Aug 2023

EPS came in at -$0.66 , while revenue for the quarter reached $339.90M .

Earnings released on 1 Apr 2023

EPS came in at -$1.49 , while revenue for the quarter reached $760.43M .

Earnings released on 23 Aug 2022

EPS came in at $0.12 , while revenue for the quarter reached $1.20B .

Earnings released on 31 Dec 2021

EPS came in at $0.02 , while revenue for the quarter reached $87.68M .

Earnings released on 30 Jun 2021

EPS came in at -$0.02 , while revenue for the quarter reached $195.71M .

Earnings released on 31 Dec 2020

EPS came in at -$0.05 , while revenue for the quarter reached $370.93M .

0911.HK Stock Performance

Access detailed 0911.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run